Collegium Pharmaceutical (COLL) EPS (Basic) (2014 - 2026)

Collegium Pharmaceutical's EPS (Basic) history runs 13 years deep, the most recent figure standing at $0.45 for Q1 2026.

• In Q1 2026, EPS (Basic) rose 462.5% year-over-year to $0.45; the TTM figure through Mar 2026 stood at $2.37 (up 74.26% YoY), while the FY2025 annual figure was $1.98, down 7.48% from the prior year.
• EPS (Basic) was $0.45 for Q1 2026 at Collegium Pharmaceutical, down from $0.54 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $1.0 in Q3 2025 to a low of -$0.51 in Q1 2023.
• Historically, EPS (Basic) has averaged $0.31 across 5 years, with a median of $0.38 in 2023.
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 186.67% in 2022, then surged 6000.0% in 2023.
• A 5-year view of EPS (Basic) shows it stood at -$0.21 in 2022, then surged by 571.43% to $0.99 in 2023, then slumped by 60.61% to $0.39 in 2024, then soared by 38.46% to $0.54 in 2025, then fell by 16.67% to $0.45 in 2026.
• The last three EPS (Basic) figures came in at $0.45 (Q1 2026), $0.54 (Q4 2025), and $1.0 (Q3 2025), per Business Quant data.